News Briefing channel feed

Zan­tac pulled off shelves due to can­cer scare; The end of the road for Mo­tif Bio

6 years ago

Pro­lif­ic In­sil­i­co scores up to $200M deal in Chi­na; Re­searchers re­tract pa­per on gene in­volved in CRISPR ba­by con­tro­ver­sy

6 years ago

Gilead files for fil­go­tinib in Japan; Alzheimer's flop forces some painful next steps at Neu­rotrope

6 years ago

DB­V's peanut al­ler­gy patch is fi­nal­ly un­der FDA re­view; Rit­ter swal­lows bit­ter pill to ex­plore strate­gic al­ter­na­tives

6 years ago

Em­ma Walm­s­ley joins #MeToo­Pay; Monopar post­pones $40M IPO

6 years ago

NICE fails to en­dorse Roche's Tecen­triq for breast can­cer; Eli­cio clos­es fi­nanc­ing round with $33M

6 years ago

More bad news for Sarep­ta; No­var­tis, Mi­crosoft join forces in AI pact

6 years ago

For­mer Akcea pres­i­dent makes the leap to CEO seat at Avid­i­ty Bio­sciences; Astel­las in­vests $12.5M in­to two in­cu­ba­tors

6 years ago

Mer­ck touts Phase III da­ta for an­tibac­te­r­i­al Re­car­brio; Sanofi to ax 200 jobs in Japan — re­port

6 years ago

T3 Phar­ma­ceu­ti­cals com­pletes sec­ond fi­nanc­ing round; Mod­er­na, Har­vard Med­ical School to tack­le im­muno­log­i­cal dis­eases

6 years ago

BioN­Tech lays out plans for $251M IPO; Trio teams up to form joint lab to re­search chron­ic lung dis­eases

6 years ago

Eli Lil­ly dish­es out first mile­stone pay­ment for Alzheimer's deal; ADC Ther­a­peu­tics, Viela Bio set terms for IPO

6 years ago

As­traZeneca vet heads to UK biotech as the new CSO; Mallinck­rodt touts pos­i­tive PhI­II da­ta

6 years ago

Astel­las/Fi­bro­Gen's ane­mia drug for CKD pa­tients ap­proved in Japan; Re­searchers pro­pose com­bo to stay ahead of KRAS re­sis­tance

6 years ago

Alzheimer’s re­search in line for $350M boost as Sen­ate pro­pos­es $3B hike to NIH bud­get; Al­lo­gene teams up with Stan­ford re­searchers

6 years ago

vTv Ther­a­peu­tics re­ports ad­di­tion­al pos­i­tive PhII da­ta; Shang­hai Hen­lius prices $410 mil­lion IPO at bot­tom of range

6 years ago

Am­gen inks dis­cov­ery deal with Hum­ming­bird; Mer­ck gains pri­or­i­ty re­view for Ebo­la vac­cine

6 years ago

As­traZeneca's di­a­betes drug grant­ed fast track des­ig­na­tion for heart fail­ure; Ver­ri­ca sends skin in­fec­tion treat­ment to FDA

6 years ago

Wood­ford forced to write down val­ues of hold­ings; No­var­tis show­cas­es pos­i­tive PhI­II MS da­ta

6 years ago

Bay­er trims 2 top ex­ecs, shrinks man­age­ment board; Spring­Works boosts size of IPO

6 years ago

Big Phar­ma joins £200M UK Biobank se­quenc­ing project; Monopar sets terms for $40M IPO

6 years ago

Atom­wise, On­coStatyx launch JV to tar­get triple-neg­a­tive breast can­cer; Can­cer biotech woos for­mer Spark COO John Furey

6 years ago

Neu­rotrope bat­tered in lat­est Alzheimer's flop; Platelet Bio­Gen­e­sis rais­es $26M-plus

6 years ago

BioN­Tech part­ners with Bill and Melin­da Gates Foun­da­tion, scor­ing $55M eq­ui­ty in­vest­ment; BeiGene brush­es off short at­tack

6 years ago
First page Previous page 46474849505152 Next page Last page
A service from the Financial Times